A biomimetic approach for enhancing the in vivo half-life of peptides-Reference-Cited by-同舟云学术

A biomimetic approach for enhancing the in vivo half-life of peptides

Published:2015-09-07 Issue:10 Volume:11 Page:793-798
ISSN:1552-4450
Container-title:Nature Chemical Biology
language:en
Short-container-title:Nat Chem Biol

Author:

Penchala Sravan C,Miller Mark R,Pal Arindom,Dong Jin,Madadi Nikhil R,Xie Jinghang,Joo Hyun,Tsai Jerry,Batoon Patrick,Samoshin Vyacheslav,Franz Andreas,Cox Trever,Miles Jesse,Chan William K,Park Miki S,Alhamadsheh Mamoun M

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Molecular Biology

Link

http://www.nature.com/articles/nchembio.1907.pdf

Reference40 articles.

1. Boohaker, R.J., Lee, M.W., Vishnubhotla, P., Perez, J.M. & Khaled, A.R. The use of therapeutic peptides to target and to kill cancer cells. Curr. Med. Chem. 19, 3794–3804 (2012).

2. Kaspar, A.A. & Reichert, J.M. Future directions for peptide therapeutics development. Drug Discov. Today 18, 807–817 (2013).

3. Tweedle, M.F. Peptide-targeted diagnostics and radiotherapeutics. Acc. Chem. Res. 42, 958–968 (2009).

4. Morgat, C. et al. Targeting neuropeptide receptors for cancer imaging and therapy: perspectives with bombesin, neurotensin, and neuropeptide-Y receptors. J. Nucl. Med. 55, 1650–1657 (2014).

5. Kontermann, R. in Therapeutic Proteins: Strategies to Modulate Their Plasma Half-lives (Wiley-VCH, Weinheim, 2012).

Cited by 105 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hybrid Diffusion Model for Stable, Affinity-Driven, Receptor-Aware Peptide Generation;Journal of Chemical Information and Modeling;2024-08-28

2. Engineering aspects of lipid-based delivery systems: In vivo gene delivery, safety criteria, and translation strategies;Biotechnology Advances;2024-05

3. Development of peptides for targeting cell ablation agents concurrently to the Sertoli and Leydig cell populations of the testes: An approach to non-surgical sterilization;PLOS ONE;2024-04-04

4. Design and Preclinical Evaluation of a Novel Prostate-Specific Membrane Antigen Radioligand Modified with a Transthyretin Binder;Cancers;2024-03-23

5. A Hybrid Diffusion Model for Stable, Affinity-Driven, Receptor-Aware Peptide Generation;2024-03-16